Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
alessandro.pulsoni@uniroma1.it
Alessandro Pulsoni
Professore Associato
Struttura:
DIPARTIMENTO DI MEDICINA TRASLAZIONALE E DI PRECISIONE
E-mail:
alessandro.pulsoni@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia
BRITISH JOURNAL OF HAEMATOLOGY
2022
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study
BLOOD CANCER JOURNAL
2022
Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study
BLOOD
2022
Hairy cell leukaemia with low CD103 expression: A rare but important diagnostic pitfall
BRITISH JOURNAL OF HAEMATOLOGY
2022
Brentuximab Vedotin and Bendamustine Produce Long-Term Clinical Benefit in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter Real-Life Experience
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
2022
Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders
AMERICAN JOURNAL OF HEMATOLOGY
2021
Vemurafenib plus rituximab in refractory or relapsed hairy-cell leukemia
NEW ENGLAND JOURNAL OF MEDICINE
2021
Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi
ANNALS OF HEMATOLOGY
2021
High basal maximal standardized uptake value (Suvmax) in follicular lymphoma identifies patients with a low risk of long-term relapse
CANCERS
2021
Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: Final results of FIL HD0801 trial
BLOOD ADVANCES
2021
Pembrolizumab for relapsed or refractory Hodgkin lymphoma
THE LANCET ONCOLOGY
2021
MRI versus CT and PET/CT in the preoperative assessment of Hodgkin and non-Hodgkin lymphomas
HEMATO
2021
The current role of interferon in hairy cell leukaemia: clinical and molecular aspects
BRITISH JOURNAL OF HAEMATOLOGY
2021
Blastic plasmocitoid dendritic cell neoplasm with leukemic spread: a GIMEMA survey
BLOOD ADVANCES
2021
The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments
ANNALS OF HEMATOLOGY
2020
Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study
ANNALS OF HEMATOLOGY
2020
A stereotyped light chain may shape virus-specific B-cell receptors in HCV-dependent lymphoproliferative disorders
GENES AND IMMUNITY
2020
Human herpesvirus-8–positive primary effusion lymphoma in HIV-negative patients: single institution case series with a multidisciplinary characterization
CANCER CYTOPATHOLOGY
2020
Five-year results of the {BEGEV} salvage regimen in relapsed/refractory classical Hodgkin lymphoma
BLOOD ADVANCES
2020
Hodgkin's lymphoma: post- autologous transplantation consolidation therapy.
ACTA BIOMEDICA
2020
« prima
< precedente
1
2
3
4
seguente ›
ultima »
Progetti di Ricerca
STUDIO RETROSPETTIVO SUL RUOLO PROGNOSTICO DELLA QUALITA' DELLA RISPOSTA ALLA PET DI FINE TRATTAMENTO VALUTATA SECONDO IL "DEAUVILLE SCORE", IN PAZIENTI CON LINFOMA DI HODGKIN CLASSICO, TRATTATI CON ABVD
RUOLO PROGNOSTICO DELLA PET DI FINE TRATTAMENTO NEL LINFOMA DI HODGKIN CLASSICO TRATTATO SECONDO SCHEMA ABVD: RIVALUTAZIONE CENTRALIZZATA DELLA PET SECONDO DEAUVILLE SCORE.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma